Patents Assigned to Ciber Enfermedades Respiratorias
  • Genetically modified mesenchymal stem cells expressing sST2 for the treatment of airway immune inflammatory and lung disease
    Patent number: 9339518
    Abstract: The present invention relates to mesenchymal stem cells (MSC) genetically modified to express sST2 or parts thereof for use in the treatment of airway immune inflammatory and lung diseases, wherein said mesenchymal stem cells are not human embryonic stem cells. The present invention also relates to pharmaceutical compositions comprising said mesenchymal stem cells.
    Type: Grant
    Filed: November 23, 2012
    Date of Patent: May 17, 2016
    Assignees: Fundacio Institut D'Investigacio Biomedica De Bellvitge (IDIBELL), Ciber Enfermedades Respiratorias, Fundacio Institut De Recerca Hospital Universitari Vall D'Hebron
    Inventors: Josep Maria Aran Perramon, Maria Jesus Cruz Carmona, Itziar Martinez Gonzalez, Oriol Roca Gas, Joan Ramon Masclans Enviz, Javier Munoz Gall
  • ENGINEERED STEM CELLS AND THEIR THERAPEUTIC USE
    Publication number: 20140315298
    Abstract: The present invention relates to mesenchymal stem cells (MSC) genetically modified to express sST2 or parts thereof for use in the treatment of airway immune inflammatory and lung diseases, wherein said mesenchymal stem cells are not human embryonic stem cells. The present invention also relates to pharmaceutical compositions comprising said mesenchymal stem cells.
    Type: Application
    Filed: November 23, 2012
    Publication date: October 23, 2014
    Applicants: Fundacio Institut D'Investigacio Biomedica De Bellvitge (IDIBELL), Ciber Enfermedades Respiratorias, Fundacio Institut De Recerca Hospital Universitari Vall D'Hebron
    Inventors: Josep Maria Aran Perramon, Maria Jesus Cruz Carmona, Itziar Martinez Gonzalez, Oriol Roca Gas, Joan Ramon Masclans Enviz, Javier Munoz Gall